Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Hematopoietic stem cell transplantation Stories

2013-05-01 08:28:39

The Supermodel Joins Katharina Harf of Delete Blood Cancer and Founding Corporate Sponsor Coty Inc. to Raise Awareness for the Cause NEW YORK, May 1, 2013 /PRNewswire/ -- Today, internationally renowned supermodel Georgia May Jagger will join Delete Blood Cancer, part of the world's largest bone marrow donor center, and leading global beauty company Coty Inc. to light up the Empire State Building in red and white to help raise awareness for the fight against blood cancer. Jagger will...

2013-04-29 12:28:22

SCHAUMBURG, Ill., April 29, 2013 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA) announced the appointment of Istvan Redei, MD, as National Director of Stem Cell Transplant and Cell Therapy. Dr. Redei, is based at the CTCA Midwestern Regional Medical Center in Zion, Illinois where he continues to serve as the Director of Stem Cell Therapy and Cell Therapy Program. Since joining CTCA he and his team have been responsible for treating over 700 analytic hematologic...

2013-04-24 15:40:46

Nearly two-thirds of children receiving stem cell transplants returned to the hospital within six months for treatment of unexplained fevers, infections or other problems, according to a study performed at Dana-Farber/Children's Hospital Cancer Center in Boston. Children who received donor cells were twice as likely to be readmitted as children who received their own stem cells. "No one had ever looked at these data in children," said Leslie E. Lehmann, MD, clinical director of pediatric...

2013-04-08 11:59:32

Journal of American College of Surgeons study reports that, despite the risks and the costs, liver transplant may also serve as a model for gene therapy through solid organ transplantation for some patients Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases.  Among the main considerations are the anxiety of waiting for a donor...

2013-04-04 08:29:53

Major milestone achieved as orphan status grants Enlivex seven years of exclusivity for treatment based on immune tolerance for GVHD JERUSALEM, April 4, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, announced today that one of its flagship portfolio companies, Enlivex...

2013-03-27 08:31:27

PRINCETON, N.J., March 27, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration (FDA) has completed its review and cleared the Investigational New Drug (IND) application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients. Clearance of the IND allows Soligenix to initiate a Phase 2,...

2013-03-26 16:28:14

SNOWMASS, Colo., March 26, 2013 /PRNewswire/ -- Howard Leonhardt of Bioheart, Inc., and Leonhardt Ventures will be presenting his team's experience with stem cell transplantation at the 28(th) Annual International Symposium of Interventional Cardiology. The conference, which will explore a comprehensive approach to the percutaneous management of structural heart disease and coronary and peripheral vascular disease, will be held at the Westin Hotel in Snowmass Village, Colo., from March 24 -...

2013-03-21 14:58:25

Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides. The therapy may not be effective for all patients, but those with trisomy 8 chromosomal disorder have higher rates of stable disease and respond better to treatment with dasatinib,...

Researchers Tackle Leukemia With Engineered T-Cell Therapy
2013-03-21 15:08:12

Brett Smith for redOrbit.com - Your Universe Online Job training can allow workers to take on new responsibilities and a team of oncologists from Memorial Sloan-Kettering Cancer Center (MSKCC) in New York found that the same thing applies to the body´s immune system. By essentially taking T cells, a type of white blood cell, back to school — the oncologists were able to successfully eradicate a certain type of acute leukemia. Similar previous research has shown promise in...

2013-03-21 08:28:53

Leading bone marrow donor center unveils aggressive nationwide initiative under new name to boost donor numbers NEW YORK, March 21, 2013 /PRNewswire/ -- Every year, more than 12,000 patients in the U.S. are diagnosed with blood cancers for which a bone marrow transplant may be their only hope for a cure. 70% of patients in need rely on a perfect stranger for a bone marrow donation. DKMS Americas, part of the world's largest bone marrow donor center announced today that they are...


Latest Hematopoietic stem cell transplantation Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »